Basir Eye health Research Center
  • Register
  • Login

Journal of Ophthalmic and Optometric Sciences

  • Home
  • About
    • About the Journal
    • Editorial Policies
    • Indexing & Abstracting
    • Privacy Statement
  • Current Issue
  • Archives
  • Editorial Team
  • Ethical Considerations
  • Copy Right Form
  • Author Guidelines
  • Submit Article
  • COPE Compliance
  • Contact
Advanced Search
  1. Home
  2. Archives
  3. Vol. 4 No. 3 (2020): Summer
  4. Case Reports

Vol. 4 No. 3 (2020)

June 2020

Surgically Induces Scleral Melting Improved by Topical Erythropoietin: A Case Report

  • Maryam Yadgari
  • Fatema Jafari
  • Hashem Ahmad Hassan

Journal of Ophthalmic and Optometric Sciences, Vol. 4 No. 3 (2020), 23 June 2020 , Page 50-53
https://doi.org/10.22037/joos.v4i3.38513 Published: 2020-06-23

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Surgically induced scleral necrosis is a rare complication after many types of ocular surgery, including cataract surgery, pterygium surgery, glaucoma surgery, and vitrectomies. This report discusses a 35-year-old woman with Type I diabetes mellitus with multiple episodes of ocular surgeries, including glaucoma device implantation. The subject presented to our clinic with ocular pain and vision loss in the right eye following reoperation for glaucoma device implantation. The subject was managed successfully with topical erythropoietin in her episode of scleral melting. In this case, successful epithelialization and vascularization of the conjunctival defect were observed with the use of topical erythropoietin, resulting in putting off another reoperation. This indicates the usefulness of topical erythropoietin in successfully managing surgically-induced scleral melting cases.

Keywords:
  • Scleral melting
  • , Erythropoietin
  • Glaucoma
  • pdf

How to Cite

Yadgari, M., Jafari, F., & Ahmad Hassan, H. . (2020). Surgically Induces Scleral Melting Improved by Topical Erythropoietin: A Case Report. Journal of Ophthalmic and Optometric Sciences, 4(3), 50–53. https://doi.org/10.22037/joos.v4i3.38513
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Doshi RR, Harocopos GJ, Schwab IR, Cunningham Jr ET. The spectrum of postoperative scleral necrosis. Survey of ophthalmology. 2013;58(6):620-33.

Feizi S, Alemzadeh-Ansari M, Baradaran-Rafii A, Esfandiari H, Kheirkhah A. Topical erythropoietin for treatment of scleral necrosis. Ocular Immunology and Inflammation. 2021:1-6.

Mansour AM, Bashshur Z. Surgically induced scleral necrosis. Eye. 1999;13(6):723-4.

O'Donoghue E, Lightman S, Tuft S, Watson P. Surgically induced necrotising sclerokeratitis (SINS)--precipitating factors and response to treatment. British Journal of Ophthalmology. 1992;76(1):17-21.

Feizi S, Alemzadeh-Ansari M, Karimian F, Esfandiari H. Use of erythropoietin in ophthalmology: A review. Survey of Ophthalmology. 2021.

  • Abstract Viewed: 132 times
  • pdf Downloaded: 132 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact
Powered by OJSPlus